Literature DB >> 3086887

Role of hydrogen peroxide and hydroxyl radical formation in the killing of Ehrlich tumor cells by anticancer quinones.

J H Doroshow.   

Abstract

The cytotoxicity of the clinically important antineoplastic quinones doxorubicin, mitomycin C, and diaziridinylbenzoquinone for the Ehrlich ascites carcinoma was significantly reduced or abolished by the antioxidant enzymes catalase and superoxide dismutase, the hydroxyl radical scavengers dimethyl sulfoxide, diethylurea, and thiourea, and the iron chelators deferoxamine, 2,2-bipyridine, and diethylenetriaminepentaacetic acid. However, tumor cell killing by 5-iminodaunorubicin, a doxorubicin analog with a modified quinone function that prohibits oxidation-reduction cycling, was not ameliorated by any of the free radical scavengers tested. Furthermore, treatment of intact tumor cells with doxorubicin, mitomycin C, and diaziridinylbenzoquinone but not 5-iminodaunorubicin generated the hydroxyl radical, or a related chemical oxidant, in vitro in a process that required hydrogen peroxide, iron, and intact tumor cells. These results suggest that drug-induced hydrogen peroxide and hydroxyl radical production may play a role in the antineoplastic action of redox active anticancer quinones.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3086887      PMCID: PMC323764          DOI: 10.1073/pnas.83.12.4514

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  A protective function of superoxide dismutase during respiratory chain activity.

Authors:  D D Tyler
Journal:  Biochim Biophys Acta       Date:  1975-09-08

2.  Comparison of in vitro methods to determine drug-induced cell lethality.

Authors:  P R Roper; B Drewinko
Journal:  Cancer Res       Date:  1976-07       Impact factor: 12.701

3.  Protective effect of superoxide dismustase on erythrocytes of x-irradiated mice.

Authors:  A Petkau; K Kelly; W S Chelack; C Barefoot
Journal:  Biochem Biophys Res Commun       Date:  1976-05-17       Impact factor: 3.575

4.  Lysosomal enzyme release from human leukocytes: mediation by the alternate pathway of complement activation.

Authors:  I M Goldstein; M Brai; A G Osler; G Weissmann
Journal:  J Immunol       Date:  1973-07       Impact factor: 5.422

5.  The incorporation of 3H-cytosine arabinoside and its effect on murine leukemic cells (L5178Y).

Authors:  M Y Chu; G A Fischer
Journal:  Biochem Pharmacol       Date:  1968-05       Impact factor: 5.858

Review 6.  Mitomycin C: a review.

Authors:  S T Crooke; W T Bradner
Journal:  Cancer Treat Rev       Date:  1976-09       Impact factor: 12.111

7.  Effects of dimethyl sulfoxide and thiourea upon intercalator-induced DNA single-strand breaks in mouse leukemia (L1210) cells.

Authors:  Y Pommier; L A Zwelling; M R Mattern; L C Erickson; D Kerrigan; R Schwartz; K W Kohn
Journal:  Cancer Res       Date:  1983-12       Impact factor: 12.701

8.  Intracellular iron-binding macromolecules in HeLa cells.

Authors:  E Robbins; J Fant; W Norton
Journal:  Proc Natl Acad Sci U S A       Date:  1972-12       Impact factor: 11.205

9.  Determinants of fecal and urinary iron excretion in desferrioxamine-treated rats.

Authors:  C Hershko
Journal:  Blood       Date:  1978-03       Impact factor: 22.113

10.  Evidence for role of hydroxyl radical in complement and neutrophil-dependent tissue injury.

Authors:  P A Ward; G O Till; R Kunkel; C Beauchamp
Journal:  J Clin Invest       Date:  1983-09       Impact factor: 14.808

View more
  60 in total

1.  Distinct roles of cytochrome P450 reductase in mitomycin C redox cycling and cytotoxicity.

Authors:  Yun Wang; Joshua P Gray; Vladimir Mishin; Diane E Heck; Debra L Laskin; Jeffrey D Laskin
Journal:  Mol Cancer Ther       Date:  2010-05-25       Impact factor: 6.261

2.  Doxorubicin pathways: pharmacodynamics and adverse effects.

Authors:  Caroline F Thorn; Connie Oshiro; Sharon Marsh; Tina Hernandez-Boussard; Howard McLeod; Teri E Klein; Russ B Altman
Journal:  Pharmacogenet Genomics       Date:  2011-07       Impact factor: 2.089

3.  Polyamines alleviate the inhibitory effect of the DNA cross-linking agent mitomycin C on root growth.

Authors:  Hidenori Tanaka; Kazuya Takeda; Akihiro Imai
Journal:  Plant Signal Behav       Date:  2019-08-26

4.  Modulation of selenium-dependent glutathione peroxidase activity enhances doxorubicin-induced apoptosis, tumour cell killing and hydroxyl radical production in human NCI/ADR-RES cancer cells despite high-level P-glycoprotein expression.

Authors:  James H Doroshow; Agnes Juhasz
Journal:  Free Radic Res       Date:  2019-07-30

5.  Transgenic mice with increased Cu/Zn-superoxide dismutase activity: animal model of dosage effects in Down syndrome.

Authors:  C J Epstein; K B Avraham; M Lovett; S Smith; O Elroy-Stein; G Rotman; C Bry; Y Groner
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

Review 6.  Homologous Recombination Deficiency: Exploiting the Fundamental Vulnerability of Ovarian Cancer.

Authors:  Panagiotis A Konstantinopoulos; Raphael Ceccaldi; Geoffrey I Shapiro; Alan D D'Andrea
Journal:  Cancer Discov       Date:  2015-10-13       Impact factor: 39.397

Review 7.  Roles for MDC1 in cancer development and treatment.

Authors:  Sophie E Ruff; Susan K Logan; Michael J Garabedian; Tony T Huang
Journal:  DNA Repair (Amst)       Date:  2020-08-11

Review 8.  Redox control of leukemia: from molecular mechanisms to therapeutic opportunities.

Authors:  Mary E Irwin; Nilsa Rivera-Del Valle; Joya Chandra
Journal:  Antioxid Redox Signal       Date:  2012-09-28       Impact factor: 8.401

9.  Deoxyamphimedine, a pyridoacridine alkaloid, damages DNA via the production of reactive oxygen species.

Authors:  Kathryn M Marshall; Cynthia D Andjelic; Deniz Tasdemir; Gisela P Concepción; Chris M Ireland; Louis R Barrows
Journal:  Mar Drugs       Date:  2009-05-25       Impact factor: 5.118

10.  Inhibition of mitomycin C's aerobic toxicity by the seleno-organic antioxidant PZ-51.

Authors:  D L Gustafson; C A Pritsos
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.